Michelle Lee

Medicine & Life Sciences

1. Breast 100%
2. palbociclib 64%
3. Breast Neoplasms 63%
4. Cyclin-Dependent Kinase 6 62%
5. Progressive Myoclonic Epilepsy 61%
6. Mastodynia 59%
7. Anastrozole 58%
8. Cyclin-Dependent Kinase 4 57%
9. Spinal Muscular Atrophy 52%
10. Malpractice 50%
11. antineoplaston A10 49%
12. Neoplasms 49%
13. Female Genitalia 48%
14. Ceramides 48%
15. Jurisprudence 47%
16. Hereditary Neoplastic Syndromes 45%
17. human ASAH1 protein 42%
18. Embolism 41%
19. Genitalia 37%
20. Estrogens 33%
21. Thorax 28%
22. Tomography 27%
23. Acid Ceramidase 23%
24. Ovarian Neoplasms 22%
25. Endometrial Neoplasms 20%
26. Hereditary Breast and Ovarian Cancer Syndrome 17%
27. Radiologists 15%
28. Fibroblasts 15%
29. Diagnostic Imaging 13%
30. Hereditary Nonpolyposis Colorectal Neoplasms 13%
31. Atherosclerotic Plaques 12%
32. Mutation 12%
33. Accidents 11%
34. Enzymes 11%
35. Stroke 11%
36. Surgeons 10%
37. Biopsy 10%
38. Leukocytes 10%
39. Aorta 10%
40. Radiology 10%
41. Costs and Cost Analysis 10%
42. TimeLine 8%
43. Databases 8%
44. Cell Cycle Checkpoints 8%
45. Pain 8%
46. Operating Rooms 8%
47. Colonic Neoplasms 8%
48. Compliance 8%
49. Sensorineural Hearing Loss 7%
50. Blood Vessels 7%